Trial Profile
Multiple ascending dose study of ACT 280778 in male volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs ACT 280778 (Primary)
- Indications Hypertension
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Actelion Pharmaceuticals
- 22 Mar 2013 New trial record
- 09 Mar 2013 Results presented at the 114th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.